Assetmark Inc. Buys 1,989 Shares of Cardinal Health, Inc. $CAH

Assetmark Inc. increased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 2.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 79,417 shares of the company’s stock after purchasing an additional 1,989 shares during the quarter. Assetmark Inc.’s holdings in Cardinal Health were worth $13,342,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of CAH. Greykasell Wealth Strategies Inc. bought a new stake in shares of Cardinal Health in the first quarter worth $26,000. Jones Financial Companies Lllp grew its stake in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares during the last quarter. Atlantic Edge Private Wealth Management LLC grew its stake in shares of Cardinal Health by 75.0% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares during the last quarter. GW&K Investment Management LLC grew its stake in shares of Cardinal Health by 113.4% in the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after purchasing an additional 144 shares during the last quarter. Finally, Harbor Asset Planning Inc. bought a new stake in shares of Cardinal Health in the second quarter worth $49,000. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $190.65 on Friday. The business has a 50-day simple moving average of $155.17 and a 200 day simple moving average of $154.37. Cardinal Health, Inc. has a one year low of $107.11 and a one year high of $197.67. The firm has a market capitalization of $45.29 billion, a price-to-earnings ratio of 29.56, a PEG ratio of 1.39 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.33. The business had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company’s quarterly revenue was up 22.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were issued a $0.5107 dividend. The ex-dividend date was Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.1%. Cardinal Health’s dividend payout ratio is presently 31.63%.

Insiders Place Their Bets

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the transaction, the insider owned 48,457 shares in the company, valued at approximately $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the transaction, the insider owned 15,431 shares in the company, valued at approximately $2,298,293.14. The trade was a 64.59% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on CAH shares. Wells Fargo & Company reissued an “overweight” rating and issued a $185.00 price objective (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. UBS Group boosted their target price on shares of Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a report on Friday. Citigroup boosted their target price on shares of Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a report on Friday. Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. Finally, Robert W. Baird set a $232.00 target price on shares of Cardinal Health in a report on Friday. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $175.27.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.